SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Cardiovascular Pharmacology and Therapeutics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hamzei, A.
Right arrow Articles by Karagueuzian, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamzei, A.
Right arrow Articles by Karagueuzian, H. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Role of Approximate Entropy in Predicting Ventricular Defibrillation Threshold

Ali Hamzei, MD, PhD

Toshihiko Ohara, MD

Young-Hoon Kim, MD

Moon-Hyoung Lee, MD

Olga Voroshilovski, BS

Shien-Fong Lin, PhD

James N. Weiss, MD

Peng-Sheng Chen, MD

Division of Cardiology, Departments of Medicine, Cedars-Sinai Medical Center; UCLA School of Medicine, Los Angeles, CA

Hrayr S. Karagueuzian, PhD

Division of Cardiology, Departments of Medicine, Cedars-Sinai Medical Center; UCLA School of Medicine, Los Angeles, CA; Cedars-Sinai Medical Center, Davis Research Bldg. Room 6066, 8700 Beverly Boulevard, Los Angeles, CA, 90048

Background: The role of myocardial tissue mass on ventricular defibrillation threshold (DFT) is unclear. We hypothesized that changes in tissue mass modulate DFT by changing ventricular fibrillation (VF) wavefront regularity (entropy).

Methods and Results: The right ventricles (RV) of seven farm pigs were isolated, superfused and perfused through the right coronary artery with oxygenated Tyrode's solution at 37 The epicardial surface was stained with the voltage sensitive dye, di-4-ANEPPS, and activation wavefront numbers (AWN) during VF were determined from the optical maps using a CCD camera (96 x 96 pixels over a 3.5 x 3.5 cm area). The RV mass was progressively reduced by sequential cutting of 1 to 2 g of tissue (approximately 12 cuts in total) distal to the perfusion site. After each cut, VF was reinduced, optical maps obtained, and the 50% probability of successful DFT50 determined using an up-down algorithm. After each cut, the approximate entropy (ApEn) was also computed using 5 seconds of VF data obtained with a bipolar electrode and a pseudo-electrocardiogram. Tissue mass reduction of up to one third of the RV mass (ie, from 48.4 ± 4.25 g to 34 ± 4.7 g) caused little or no change in the DFT, ApEn or AWN. However, further progressive reduction of the RV mass near the critical mass of VF resulted in a significant (P < 0.05) progressive decrease in all three measured parameters. DFT energy was reduced by 27% (1.47 ± 0.34 J vs. 1.02 ± 0.14 J). There was a significant (P < 0.01) correlation between the DFT and ApEn, which significantly further increased (P < 0.001) near the critical mass. In a separate series of 6 isolated RVs, the ApEn correlated well with the Kolmogorov-Sinai (K-S) entropy, the standard method of calculating entropy.

Conclusion: Tissue mass reduction significantly reduces DFT when the mass reduction increases VF wavefront regularity.

Key Words: ventricular fibrillation • defibrillation threshold • approximate entropy • mapping • electrical stimulation

Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 7, No. 1, 45-52 (2002)
DOI: 10.1177/107424840200700i107


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
J. D. Day, R. N. Doshi, P. Belott, U. Birgersdotter-Green, M. Behboodikhah, P. Ott, K. A. Glatter, S. Tobias, H. Frumin, B. K. Lee, et al.
Inductionless or Limited Shock Testing Is Possible in Most Patients With Implantable Cardioverter- Defibrillators/Cardiac Resynchronization Therapy Defibrillators: Results of the Multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)
Circulation, May 8, 2007; 115(18): 2382 - 2389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Yashima, Y.-H. Kim, S. Armin, T.-J. Wu, Y. Miyauchi, W. J. Mandel, P.-S. Chen, and H. S. Karagueuzian
On the mechanism of the probabilistic nature of ventricular defibrillation threshold
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H249 - H255.
[Abstract] [Full Text] [PDF]



Advertisement